AZD9056   Click here for help

GtoPdb Ligand ID: 7826

Synonyms: AZD 9056 | AZD-9056
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: AZD9056 is a potent, selective, orally bioavailable P2X7 receptor antagonist.
This compound was in the AstraZeneca/NCATS repurposing list from 2012.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 11
Topological polar surface area 61.36
Molecular weight 418.24
XLogP 5.41
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES OCCCNCCCc1ccc(c(c1)C(=O)NCC12CC3CC(C2)CC(C1)C3)Cl
Isomeric SMILES OCCCNCCCc1ccc(c(c1)C(=O)NCC12CC3CC(C2)CC(C1)C3)Cl
InChI InChI=1S/C24H35ClN2O2/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29)
No information available.
Summary of Clinical Use Click here for help
AZD9056 was developed for the treatment of inflammatory conditions such as rheumatoid arthritis (RA), chronic obstructive pulmonary disease (COPD) and Crohn’s disease. Phase 2 trial NCT00520572 for RA has been completed. There are no active trials in progress (Nov 2014).
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The molecular mechanism of action of P2X7 receptor antagonism in rheumatoid disease is reviewed by McInnes et al. (2014) [1].